HOLLENCREST CAPITAL MANAGEMENT
Position in BIO — Bio-Rad Laboratories, Inc.
CIK 1161722
NEWPORT BEACH, CA
Position in BIO
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$27,875
New position
Shares Held
100
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Medical Devices
Healthcare · as of Mar 31, 2026HOLLENCREST CAPITAL MANAGEMENT holds $11,598,618 across 11 Medical Devices names. BIO ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
25,438 | $8,358,672 | |
| 2 | EW |
Edwards Lifesciences Corp
|
36,121 | $2,892,569 | |
| 3 | ABT |
Abbott Laboratories
|
1,561 | $160,267 | |
| 4 | BSX |
Boston Scientific Corp
|
1,181 | $74,107 | |
| 5 | QSI |
Quantum-Si Inc
|
40,111 | $31,045 | |
| 6 | BIO |
Bio-Rad Laboratories, Inc.
This page
|
100 | $27,875 | |
| 7 | GMED |
Globus Medical Inc
|
294 | $25,331 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
199 | $14,164 |
All Filings in BIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $27,875 | 100 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||